Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Industry News
FDA Approves Zyprexa for Bipolar Disorder Symptom
March 31st, 2000
Pharmaceutical group Eli Lilly and Co. said the U.S. Food and Drug Administration (FDA) has approved Zyprexa as a short-term treatment of acute manic episodes associated with bipolar disorder. Bipolar disorder, also known as manic depressive illness, is a lifelong condition characterized by disruptive swings in mood - from manic episodes, marked by euphoria and irritability, to periods of depression. People with bipolar disorder also may experience mixed episodes, marked by symptoms of mania and clinical depression occurring simultaneously. About three million Americans suffer from bipolar disorder and an estimated one in four with the illness attempts suicide, one...
Source: Drug Week (2000-03-31)
|
